ÂÜÀòÂÒÂ×

The Research and Development team at Telix Pharma is dedicated to advancing innovative diagnostic and therapeutic solutions utilizing Molecularly Targeted Radiation (MTR). Comprising experts like the Chief Scientist and General Manager of Isotope Strategy, the team collaborates to identify and develop new product candidates, optimize existing therapies, and evaluate market strategies through comprehensive analysis and strategic planning. Their goal is to enhance patient outcomes through cutting-edge biopharmaceutical research.